当前位置:首页 - 行情中心 - 圣湘生物(688289) - 财务分析 - 现金流量表

圣湘生物

(688289)

  

流通市值:127.29亿  总市值:127.29亿
流通股本:5.79亿   总股本:5.79亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,165,438,726.07754,411,397.4373,157,695.471,732,266,862.67
  收到的税费返还19,573,204.932,075,796.951,844,873.61,050,811.3
  收到其他与经营活动有关的现金91,249,045.729,242,015.389,525,123.98149,949,373.26
  经营活动现金流入小计1,276,260,976.7785,729,209.73384,527,693.051,883,267,047.23
  购买商品、接受劳务支付的现金410,703,664.37274,310,770.04106,202,179.92375,469,613.21
  支付给职工以及为职工支付的现金413,979,198.36292,071,383.83166,159,172.47515,320,930.5
  支付的各项税费98,159,562.277,772,148.1331,163,311.61113,392,351.73
  支付其他与经营活动有关的现金437,898,603.44284,421,748.75114,819,675.52604,636,295.68
  经营活动现金流出小计1,360,741,028.37928,576,050.75418,344,339.521,608,819,191.12
  经营活动产生的现金流量净额-84,480,051.67-142,846,841.02-33,816,646.47274,447,856.11
二、投资活动产生的现金流量:
  收回投资收到的现金827,033,179.49550,459,322.485,802,492.931,530,794,631.18
  取得投资收益收到的现金5,925,206.634,570,623.12,512,502.9214,609,516.2
  处置固定资产、无形资产和其他长期资产收回的现金净额1,744,428.23430,695.32-251,107.98
  收到的其他与投资活动有关的现金161,748,184.76160,406,184.76167,666,681.61-
  投资活动现金流入小计996,450,999.11715,866,825.58255,981,677.461,545,655,255.36
  购建固定资产、无形资产和其他长期资产支付的现金172,108,929.87109,025,361.8347,881,221.18421,104,874.3
  投资支付的现金1,820,333,333.341,506,333,333.34795,600,0001,167,125,181
  取得子公司及其他营业单位支付的现金---1,068,642.86
  支付其他与投资活动有关的现金---58,278,161.51
  投资活动现金流出小计1,992,442,263.211,615,358,695.17843,481,221.181,647,576,859.67
  投资活动产生的现金流量净额-995,991,264.1-899,491,869.59-587,499,543.72-101,921,604.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金---29,046,986.68
  其中:子公司吸收少数股东投资收到的现金---7,595,127.72
  取得借款收到的现金1,102,782,275942,782,275817,000,000403,130,000
  收到其他与筹资活动有关的现金6,302,199.136,302,199.136,302,199.13-
  筹资活动现金流入小计1,109,084,474.13949,084,474.13823,302,199.13432,176,986.68
  偿还债务支付的现金418,530,000394,130,000394,130,0009,000,000
  分配股利、利润或偿付利息支付的现金323,222,505.64169,338,392.056,315,276.8268,401,272.76
  支付其他与筹资活动有关的现金17,294,522.6816,687,372.414,715,521.7422,285,064.22
  筹资活动现金流出小计759,047,028.32580,155,764.45415,160,798.54299,686,336.98
  筹资活动产生的现金流量净额350,037,445.81368,928,709.68408,141,400.59132,490,649.7
四、汇率变动对现金及现金等价物的影响-389,317.971,279,806.12185,714.52-3,296.46
五、现金及现金等价物净增加额-730,823,187.93-672,130,194.81-212,989,075.08305,013,605.04
  加:期初现金及现金等价物余额4,476,628,016.924,476,628,016.924,476,628,016.924,171,614,411.88
  期末现金及现金等价物余额3,745,804,828.993,804,497,822.114,263,638,941.844,476,628,016.92
补充资料:
  净利润-142,740,148.15-226,272,700.73
  资产减值准备-8,604,506.41--43,832,062.69
  固定资产和投资性房地产折旧-73,201,522.15-112,549,189.71
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-73,201,522.15-112,549,189.71
  无形资产摊销-19,430,871.45-29,898,558.16
  长期待摊费用摊销-12,494,242.34-19,100,906.43
  处置固定资产、无形资产和其他长期资产的损失-3,044,178.72-2,362,321.35
  固定资产报废损失-91,940-1,843,247.35
  公允价值变动损失--47,493,750.56--8,408,087.48
  财务费用--34,065,418.92-18,395,334.85
  投资损失-24,953,300.33-33,698,078.42
  递延所得税-32,473,204.4-1,812,202.2
  其中:递延所得税资产减少-562,014.25-5,716,598.49
    递延所得税负债增加-31,911,190.15--3,904,396.29
  存货的减少-6,934,895.17-36,459,148.26
  经营性应收项目的减少--176,965,839.41-153,010,557.96
  经营性应付项目的增加--165,602,089.86--305,374,504.73
  其他--32,768,898.14--27,166,664.51
  现金的期末余额-3,804,497,822.11-4,476,628,016.92
  减:现金的期初余额-4,476,628,016.92-4,171,614,411.88
  现金及现金等价物的净增加额--672,130,194.81-305,013,605.04
公告日期2025-10-312025-08-302025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑